| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
| Products Intro: |
Product Name:PD-113413 CAS:103733-50-2 Purity:>98 % Remarks:Reach out to us for more information about custom solutions.
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:PD 113413 CAS:103733-50-2 Package:100mg;500mg
|
|
| | PD 113413 Basic information |
| Product Name: | PD 113413 | | Synonyms: | PD 113413;2H-Pyrazino[1,2-b]isoquinoline-2-acetic acid, 1,3,4,6,11,11a-hexahydro-3-methyl-1,4-dioxo-α-(2-phenylethyl)-, (αS,3S,11aS)- | | CAS: | 103733-50-2 | | MF: | C23H24N2O4 | | MW: | 392.44766 | | EINECS: | | | Product Categories: | | | Mol File: | 103733-50-2.mol |  |
| | PD 113413 Chemical Properties |
| Boiling point | 669.8±55.0 °C(Predicted) | | density | 1.33±0.1 g/cm3(Predicted) | | pka | 3.59±0.10(Predicted) |
| | PD 113413 Usage And Synthesis |
| Description | PD 113413 is a metabolite of quinapril. Quinapril is an angiotensin-converting enzyme inhibitor used in the treatment of hypertension and congestive heart failure. | | Uses | PD 113413 is formed by subsequent hydrolysis of the diketopiperazine quinapril analog. PD 113413 is a potent angiotensin-converting enzyme inhibitor. PD 113413 can be used for research of hypertension and congestive heart failure[1]. | | References | [1] Kaplan HR, et, al. Quinapril--a preclinical review of the pharmacology, pharmacokinetics, and toxicology. Angiology. 1989 Apr;40(4 Pt 2):335-50. DOI:10.1177/000331978904000403 |
| | PD 113413 Preparation Products And Raw materials |
|